Quality & Compliance

How important is pharmacovigilance in the post-market safety of drugs?

Real-time monitoring and analysis of biologics during manufacturing is within reach

We forge ahead to celebrate the fantastic individuals involved in bettering the pharma industry.

India has held pharma’s interest for decades, but it is a challening market to work in.

Six Sigma has the potential to deliver real cost savings by improving productivity and reducing defects, but making the change is challenging.

Mark Paxton was appointed CEO of Rx-360 in 2015. Here, he discusses the journey so far

Martin Van Trieste tells the emotional story behind the creation of Rx-360

What separates a good model from a bad model in bioprocess development?

Data, data everywhere… But pharma is not making the most out of it.

Collusion, pollution, and a pricing victory for pharma in California… what’s new in business?